|
7000 E Shea Blvd, #1010
Scottsdale, Arizona
85254
480.991.6887 | tel
602.926.2754 | fax
Click here for a map!
(Located just west of Scottsdale Rd. on the north of Shea. In
the Scottsdale Prominade center where Claim Jumpers, Eli's, Reve' Jewelers
andthe Signature Hair Salons are located. Formerly Marie When In Naples)
The Soiree Special Guest this week is
Kevin Morton, President & CEO of NeoMatrix Breast Health Solutions, and
Inventor of the NeoMatrix Halo NAF Collection System.
Kevin Morton
To contact Kevin:
Phone: |
949-753-7844 Ex. 12 |
Cell: |
949-395-7067 |
Email:
|
Kmorton@neomatrix.com |
Website: |
www.neomatrix.com |
Address: |
16 Technology Drive, Suite 118
Irvine, CA 92618
|
This week's Special Guest is Kevin Morton, President,
CEO, and Inventor of the NeoMatrix Halo NAF Collection System.
Did you know?
-
That Breast Cancer is the leading cause of death of American women between the
age of 35-50!
-
That 40,000 American women die from Breast Cancer each year!
-
That the American Cancer Society estimates that in 2004 approximately 267,000
new cases of Breast Cancer were diagnosed!
-
The average breast cancer has been growing for over seven years before it is
detected!
-
Early detection of abnormal cytology in the uterus with the Pap Test reduced
the death rate from cervical cancer by 75% making the Pap Test the most
successful cancer screening technology in history. NeoMatrix management
believes the the HALO device and disposables, a "Pap Test for the Breast" could
be just such a major breakthrough.
Breast Cancer Kills and Maims
Most of us have known a family member(s) or someone who has suffered from
Breast Cancer. Even if they beat it they often suffer scarring and emotional
trauma that can haunt them the rest of their life.
Enter Kevin Morton and NeoMatrix. Kevin has invented, developed and perfected
the HALO Breast Cancer Screening System, the first practical, non-invasive
Breast Cancer screening technology using Nipple Aspirate Fluid from the breast
for cytological screening.
The Halo Breast Cancer Screening System automatically extracts fluid from
non-lactating women with little discomfort compared with current methods, which
can be very painful.
Below is The NeoMatrix HALO NAF Collection System
|
|
|
Control Console
|
Adjustable Breast Cups |
Disposable Sample Collection Cups |
Please take a moment and view System Demo at:
http://neomatrix.com/halo_sys/demo.asp
|
Repeating that the average Breast Cancer
has been growing for seven years prior to being detected it is imperative to
detect Breast Cancer much sooner if we are to treat the disease early and save
lives.
95% of breast carcinomas start in the fluid ducts. There are 8-12 milk ducts in
a woman's breast. The Pap Smear early detection of abnormal cytology resulted
in a 75% reduction in deaths from cervical cancer. The HALO Breast Cancer
Screening System is similar in that it detects abnormal cells before they
become a tumor. By the time mammography detects a lump it's already a tumor.
The Patent Portfolio for it's HALO Technology includes 6 patents issued to
date, and 6 additional U.S. patents pending, 5 published, with a total of 260
claims relating to Nipple Aspirate Fluid screening and has received FDA
approval.
The HALO Breast Cancer Screening System from NeoMatrix has completed multiple
clinical trials that demonstrate the efficacy of the Halo system.
Please join us at this Wednesday's Soiree to meet Kevin Morton, inventor of the
HALO Breast Cancer Screening System, and to discuss investment opportunities
within the medical field.
**Special Note: NeoMatrix will also be my Special Guest for this Summer Seasons
first Yacht Party. Joining us aboard will be NeoMatrix's management team as
well as many other distiguished guests.
It is with great pleasure that Kevin
Morton, President & CEO, NeoMatrix Breast Health Solutions, will be my Special
Guest this week.
Please plan on joining us to socialize and
meet new friends.
BBB
|